Literature DB >> 18446443

Identification of the cyclin D1b mRNA variant in mouse.

Jack Wu1, Si-hung Wu, Aliccia Bollig, Archana Thakur, D Joshua Liao.   

Abstract

Cyclin D1 plays a key regulatory role during the G1 phase of the cell cycle and its gene is amplified and over-expressed in many cancers. The cyclin D1b mRNA variant was established in human cells and recent functional analyses revealed that its protein product harbors unique activities in human cancer cells. By performing reverse transcription-polymerase chain reaction (RT-PCR) and rapid amplification of cDNA ends (RACE) experiments, we identified the cyclin D1b mRNA variant in mouse. Similar to its human counterpart, the mouse cyclin D1b transcript consists of exon 1, 2, 3, 4 and part of intron 4, and contains a long open reading frame (ORF). The predicted peptide from this ORF is 34-amino acid longer than the human cyclin D1b. The expression of this mouse mRNA variant was investigated. It appears to be expressed ubiquitously and differentially in various mouse cell lines and tissues and its level might be proportional to that of the canonical endogenous cyclin D1a mRNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446443      PMCID: PMC3882314          DOI: 10.1007/s11033-008-9267-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  21 in total

Review 1.  Perturbation of cell cycle regulators in human cancer.

Authors:  I Palmero; G Peters
Journal:  Cancer Surv       Date:  1996

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.

Authors:  Nathalie Carrère; Marc-Antoine Belaud-Rotureau; Pierre Dubus; Marie Parrens; Antoine de Mascarel; Jean-Philippe Merlio
Journal:  Haematologica       Date:  2005-06       Impact factor: 9.941

Review 4.  D-type cyclins.

Authors:  C J Sherr
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

5.  c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.

Authors:  Hector Biliran; Sanjeev Banerjee; Archana Thakur; Fazlul H Sarkar; Aliccia Bollig; Fakhara Ahmed; Jiusheng Wu; Yuan Sun; Joshua D Liao
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

6.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

7.  Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Authors:  Craig J Burd; Christin E Petre; Lisa M Morey; Ying Wang; Monica P Revelo; Christopher A Haiman; Shan Lu; Cecilia M Fenoglio-Preiser; Jiwen Li; Erik S Knudsen; Jiemin Wong; Karen E Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

Review 8.  The cyclin D1/PRAD1 oncogene in human neoplasia.

Authors:  A Arnold
Journal:  J Investig Med       Date:  1995-12       Impact factor: 2.895

9.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

Review 10.  The D-type cyclins and their role in tumorigenesis.

Authors:  G Peters
Journal:  J Cell Sci Suppl       Date:  1994
View more
  7 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

3.  Magnolol pretreatment attenuates heat stress-induced IEC-6 cell injury.

Authors:  Chen Mei; Sha-Sha He; Peng Yin; Lei Xu; Ya-Ran Shi; Xiao-Hong Yu; An Lyu; Feng-Hua Liu; Lin-Shu Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2016-06       Impact factor: 3.066

4.  DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.

Authors:  Sònia Najas; Juan Arranz; Pamela A Lochhead; Anne L Ashford; David Oxley; Jean M Delabar; Simon J Cook; María José Barallobre; Maria L Arbonés
Journal:  EBioMedicine       Date:  2015-01-17       Impact factor: 8.143

5.  Genetic association between cyclin D1 polymorphism and breast cancer susceptibility.

Authors:  XiaoRui Li; XiaoQing Huo; WeiWei Li; QingHui Yang; Ying Wang; XiaoChun Kang
Journal:  Tumour Biol       Date:  2014-11-17

6.  At elevated temperatures, heat shock protein genes show altered ratios of different RNAs and expression of new RNAs, including several novel HSPB1 mRNAs encoding HSP27 protein isoforms.

Authors:  Xia Gao; Keyin Zhang; Haiyan Zhou; Lucas Zellmer; Chengfu Yuan; Hai Huang; Dezhong Joshua Liao
Journal:  Exp Ther Med       Date:  2021-06-24       Impact factor: 2.447

7.  Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.

Authors:  Yafei Zhang; Xianling Zeng; Hongwei Lu; Hong Ji; Enfa Zhao; Yiming Li
Journal:  Oncotarget       Date:  2016-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.